Skip to content

1 paper indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Aug 2026

Empagliflozin Alleviates Renal Ischemia-Reperfusion Injury by Targeting AMPK/NLRP3 Signaling.

BACKGROUND Empagliflozin (EMPA), a sodium glucose cotransporter protein inhibitor, is a widely used hypoglycemic agent in clinical practice and possesses a protective effect against renal ischemia-reperfusion injury (RIRI); however, its underlying protective mechanism remains elusive. Activating NOD-like receptor prote...

J. E., Jia Wang, Jiong Zhang · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.